US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Cullinan Therapeutics, Inc. - Common Stock
(NQ:
CGEM
)
11.31
+0.51 (+4.72%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cullinan Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
↗
April 24, 2024
Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus...
Via
Benzinga
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
↗
April 24, 2024
Via
Benzinga
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
↗
April 17, 2024
U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 16, 2024
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via
Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
April 17, 2024
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Via
Benzinga
Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
↗
April 16, 2024
Cullinan shifts focus to autoimmune diseases with CLN-978, targeting systemic lupus erythematosus. Initial trial results show potential for treatment with a differentiated safety profile.
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
↗
April 16, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Cullinan Oncology: Q4 Earnings Insights
↗
March 14, 2024
Via
Benzinga
Recap: Cullinan Oncology Q3 Earnings
↗
November 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 16, 2024
Via
Benzinga
CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023
↗
March 14, 2024
CGEM stock results show that Cullinan Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
↗
January 30, 2024
Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) shares rose sharply in today’s pre-market trading as the company posted upbeat results for its second quarter.
Via
Benzinga
Analyst Ratings for Cullinan Oncology
↗
August 09, 2023
Via
Benzinga
Analyst Ratings for Cullinan Oncology
↗
July 07, 2023
Via
Benzinga
Analyst Expectations for Cullinan Oncology's Future
↗
June 15, 2023
Via
Benzinga
Expert Ratings for Cullinan Oncology
↗
June 15, 2023
Via
Benzinga
4 Analysts Have This to Say About Cullinan Oncology
↗
May 26, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
↗
May 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
↗
October 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
↗
June 15, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
April 10, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Cullinan Oncology
↗
March 27, 2023
Via
Benzinga
Why Shares of Cullinan Oncology Jumped This Week
↗
June 09, 2023
The company's presentation at a conference got the attention of analysts and investors.
Via
The Motley Fool
Week In Review: China Biopharmas Announce Three Out-Licensing Deals Totaling $2 Billion
↗
February 18, 2023
Jiangsu Hengrui Pharma out-licensed US rights for a novel small molecule EZH2 inhibitor in a $706 million agreement with Treeline Biosciences of Connecticut. Hengrui will receive an upfront payment of...
Via
Talk Markets
5 Value Stocks In The Healthcare Sector
↗
January 09, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
↗
January 02, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
↗
October 03, 2022
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...
Via
Benzinga
Insiders Buy Around $15M Of 2 Stocks
↗
June 06, 2022
Although the Dow Jones dropped by around 350 points on Friday, there were a few notable insider trades.
Via
Benzinga
Short Volatility Alert: Cullinan Oncology
↗
May 17, 2022
On Monday, shares of Cullinan Oncology, Inc. (NASDAQ: CGEM) experienced volatile short activity. After the activity, the stock price went up at 2.45% to $10.88. The overall...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 17, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >